Introduction

The trigeminal autonomic cephalalgias (TACs) are a group of primary headache disorders that includes cluster headache (CH), paroxysmal hemicrania (PH), and short-lasting unilateral neuralgiform headache attacks with conjunctival injection and tearing/cranial autonomic features (SUNCT). Hemicrania continua (HC) is a continuous unilateral headache form that, like PH, is indomethacin-responsive. HC is included in group 4 of The International Classification of Headache Disorders, second edition (ICHD-II) [1]. However, this categorization is still debated and HC is often included with the TACs [2, 3]. Moreover, some authors suggest that the two indomethacin–sensitive headaches should be in one group [4]. Compared with other primary headaches, the TACs have stereotypic features that, since they are defined in the ICHD-II diagnostic criteria [1], should, in principle, make them easily recognizable: short-lasting duration, unilateral pain location, and ipsilateral cranial autonomic symptoms (CAS). Up-to-date international therapeutic guidelines for these disorders [5] are also available. Despite these facts, diagnostic and therapeutic errors are frequently reported in the literature [6].

The aim of this study was to review all published data, available to us, on mismanagement of TACs and HC, in order to understand its causes and help improve the management of these patients. These findings have been reported in preliminary form (3rd European Headache and Migraine Trust International Congress, London, September 2012).

Review

We performed a systematic literature search for original articles reporting errors in the diagnosis, therapy or management of TACs and HC. We also looked for review articles to enrich the discussion. In addition, we considered cases of mismanagement that we have observed in our daily practice.

Literature search

A PubMed database search was performed up to 25 September 2012, using the following “combination of terms:” (“cluster headache” OR “paroxysmal hemicrania” OR SUNCT OR “short-lasting unilateral neuralgiform headache attacks with conjunctival injection and tearing” OR SUNA OR “short-lasting unilateral neuralgiform headache attacks with cranial autonomic features” OR “hemicrania continua” OR TAC OR “trigeminal autonomic cephalalgias”) AND (error OR pitfall OR misconception OR delay OR “mis-management” OR mismanagement OR undertreatment OR undertreated OR misdiagnosis OR misdiagnosed OR underdiagnosed)”. Only articles in English were considered. We also considered articles from the reference lists of the studies found to be relevant, as well as literature known, by the authors, to be relevant.

Data extraction

Two investigators (M.V and F.A.) separately examined the abstracts of all the articles identified in the literature search. Whenever the article title or abstract suggested that the publication might contain relevant data, the entire manuscript was examined. The following relevant data were extracted from the accepted articles: publication information (authors, years), type of study (case report/series, clinic-based study, population study), sample (number of patients), clinical data (final diagnosis, previous wrong diagnoses and related treatments, number and type of physicians consulted and time to correct diagnosis, incorrect treatments after correct diagnosis). Agreement for data extraction was good. There were only two cases of disagreements that were resolved by consensus.

Results

The search strategy identified 169 published articles. Of these 169 papers, 13 [6–18] were relevant, while 156 did not meet the criteria (Figure 1). An additional 9 studies [16, 19–25] were identified by checking the references of relevant papers and reviews, as well as literature that was known to be relevant by the authors. Finally relevant articles considered for a full text evaluation were 22. All of these 22 articles were included in the analysis. The data on errors in the diagnosis and treatment of TACs or HC extracted from the case reports/series and clinical/population studies considered in this review are summarized in Tables 1, 2, 3 and 4. The cumulative number of patients was 2614 (2593 of them stemmed from the articles found with the search method). Patients with CH were found to be by far the largest category of mismanaged patients reported in the literature (97,3% of the whole population reported in these studies). Six major studies, conducted in clinical or general population settings [6, 8, 13, 17, 18, 26], investigated diagnostic and/or therapeutic errors in CH patients. A study, by Eross et al., identified one patient with CH and one with HC in a series of 100 subjects who believed they had sinus headache [11] while Sjaastad & Bakketeig interviewed 1838 inhabitans (from 18 to 65-year-old) of the Vågå commune in the mountainous area of southern Norway. Seven CH patients were observed, 6 of whom were un-aware of the diagnosis [19]. Apart from one clinical series of 33 CH patients [9] and two made up of 25 and 22 HC patients, respectively [10, 15], the remaining articles were reports of single cases or small numbers of patients with TACs or HC misdiagnosed as other conditions. Data on non-optimal treatment prescribed, even after a correct diagnosis had been established, was available only for CH. This is probably explained by the fact that PH and HC are, by definition, indomethacin-responsive headaches, while SUNCT is a very rare syndrome with an extremely low number of reported cases.

Figure 1
figure 1

Flow-diagram of the review process. * by checking the references of relevant papers and reviews as well as literature that was known to be relevant by the authors.

Full size image
Table 1 Data extracted from case report/series and clinical/population studies dealing with diagnostic/therapeutic errors in CH
Full size table
Table 2 Data extracted from case reports dealing with diagnostic/therapeutic errors in PH
Full size table
Table 3 Data extracted from case reports dealing with diagnostic/therapeutic errors in SUNCT
Full size table
Table 4 Data extracted from case reports/case series dealing with diagnostic/therapeutic errors in HC
Full size table

Cluster headache

Although recent decades have seen an improvement in the time taken to diagnose CH from onset [8], the diagnostic delay for this condition is still too protracted (more than 3 years in the most recent study [6]), as is the number of physicians consulted before arriving at the correct diagnosis (generally at least 3 medical doctors). A high number of misdiagnoses was described, many of which led to unnecessary invasive and irreversible treatments. CH was most frequently misdiagnosed as: migraine, sinusitis, tooth/jaw problems, and trigeminal neuralgia. Migraine seems to be a particularly frequent misdiagnosis. The different temporal patterns of migraine and CH attacks should make it possible to distinguish between these two conditions in the typical case, but if this aspect is not reported by the patient or thoroughly investigated by the physician, confusion may arise, given that many other features of these headaches can overlap. Migraine pain is frequently severe in intensity and unilateral in 2/3 of patients [28]. In about 56% of migraine patients at least one CAS (i.e. lacrimation or conjunctival injection) is present during attacks [29]. Moreover, typical migraine features are often associated with CH attacks. A study of a large cohort of German CH patients found that CH attacks were associated with photophobia or phonophobia in 61.2% and with nausea and vomiting in 27.8%, while migraine aura preceded CH attacks in almost a quarter of the patients [17]. Unfortunately, the ICHD-II fails to mention (either in the diagnostic criteria or in the definitions and comments) that CAS may be present in migraine and that nausea, vomiting, and photo/phonophobia may be present in CH. For clinicians, it is helpful to note that photo- and phonophobia tend to be unilateral in TACs and HC while they are bilateral in migraine [28, 30], moreover nausea and vomiting are generally more frequent in migraine than in CH (especially if they occur together) [31]. Another feature that might increase the risk of misdiagnosing CH as migraine is the possibility of the pain switching sides between attacks or cluster periods [18]. Many physicians, even headache specialists, are not aware that this can happen in CH. Indeed, according to the diagnostic criteria for CH (ICHD-II, code 3.1) the pain is unilateral; furthermore, the description paragraph states that it is “strictly unilateral” while the comments section specifies that the “pain almost invariably recurs on the same side during an individual cluster period” [1]. Yet, up to 14% of CH patients may experience a side shift of pain during a cluster period, and 18% may have side shifts from one cluster period to the next [32]. A previous diagnosis of tooth/jaw problems is likely to be found in the history of CH patients, as 37% to 50% of them reported that the pain radiated to the lower jaw, upper jaw or cheek [6, 18, 32]. This comes from the fact that patients with CH often describe the pain as emanating from the midfacial region, which might be interpreted as pain originating from the teeth, jaws or temporomandibular joints. However the presence of unilateral attacks associated with relevant ipsilateral CASs that remit spontaneously within 2–3 hours even if untreated, and that relapse with a clock-like periodicity are strong clues for CH. Sinus headache (SH) is another misdiagnosis often encountered in clinical practice. According to studies on clinic-based and clinic-based plus non-clinic-based CH populations, this misdiagnosis is made in between 21% [18] and 23% [6] of CH patients. The Sinus, Allergy and Migraine Study - SAMS [11], which, adopting a different perspective, investigated 100 individuals recruited from the general population who believed they had SH, found one who fulfilled the diagnostic criteria for CH. These errors are probably due to the pain localization in CH (frontal region and upper face) and the fact that the picture typically includes CAS referred to the nose, e.g. rhinorrhea/nasal obstruction. However, whereas nasal discharge in SH is thick, purulent, malodorous and frequently accompanied by systemic symptoms such as fever, chills and sweats, in CH it is clear and fluid [1]. Another clinical feature strongly suggesting a diagnosis of CH is a clock-like regularity of attacks. CH patients are also often wrongly diagnosed with trigeminal neuralgia (TN). Even though this scenario has been clearly reported by just one study (in which 16% of CH patients had previously been diagnosed with TN), [6] it is a situation that we have frequently encountered in our clinical practice. While the localization of the pain and its duration may, to an extent, be considered somehow similar (although duration it is a matter of seconds in TN versus many minutes in CH), there are many differences between the two conditions that should aid in the differential diagnosis. These include the presence of CAS, the clock-like periodicity of the attacks, and the presence of nocturnal attacks in CH (but not in TN) and the presence of trigger points (only in TN). Nevertheless, TN is, for some reason, the first disorder that many non-headache specialists think of when faced with a patient with a recurrent facial pain condition. Headache specialists should also bear in mind the existence of cluster-tic syndrome, a rare condition characterized by coexistence of CH and TN [33, 34].

With regard to treatment, many patients, in the course of the long diagnostic work-up of their CH, were administered inappropriate therapies (quite often invasive and irreversible, i.e. dental procedures and ENT surgery). Moreover, even after the correct diagnosis, many of these patients were still prescribed with treatments not considered first-line options for CH according to the international guidelines [5] (e.g. acute treatments such as opioids or oral triptans or preventive treatment such as propranolol, amitriptyline, carbamazepine and cyproheptadine). We are also aware, from clinical reports at congresses and from our personal observations, of instances in which other non-first-line medications, such as flunarizine or single, high-dose systemic steroid infusion for preventive treatment and indomethacin for acute treatment, were prescribed in CH patients. The above medications have been found to be ineffective in clinical trials [35, 36]. Finally, up to 63% of CH sufferers used alternative therapies without finding any of them consistently effective [32].

Paroxysmal hemicrania

Although our literature review revealed few case series and case reports considering diagnostic pitfalls in PH, this condition appears to be most frequently misdiagnosed as dental pathologies. The severe intensity of the pain and its location in the cheek, jaw and maxillary areas in some attacks of PH (that in 1/3 of the cases can be pulsating in quality), may explain this confusion with dental-related pain [22]. However, the short duration of the attacks and the presence of CAS should lead the physician to the correct diagnosis. The localization of PH in the temporal, maxillary and occasionally in the ear regions, along with a certain, ipsilateral masticatory muscle tenderness, can lead to its misdiagnosis as pain associated with temporomandibular disorder (TMD) [37]. Yet, a diagnosis of TMD requires the presence of at least one of the following symptoms and signs: pain precipitated by jaw movements and/or chewing of hard /or tough food, reduced range of or irregular jaw opening, and tenderness of the joint capsule(s) of one or both TMJs [1]. Moreover, differences in the intensity of the pain (excruciating in PH versus mild-to-moderate aching pain in TMD) should guide the clinician to the correct diagnosis [37]. The excruciating intensity of PH pain, which also can involve the territories of the second and even third trigeminal branches, and its intermittent temporal pattern may result in an incorrect diagnosis of trigeminal neuralgia (TN), especially in the ca. 10% of PH patients in whom attacks can be precipitated by mechanical triggers [38]. However, the triggers in the two conditions differ: in PH, attacks can be precipitated by head flexion or rotation or external pressure over the C2 root, the transverse processes of C4-C5, or the greater occipital nerve on the symptomatic side [38], whereas in TN they can be triggered by actions such as washing the face, shaving, smoking, talking and/or brushing the teeth, or by touching certain small areas in the nasolabial fold and/or chin [1, 39]. Unfortunately, the ICHD-II mentions trigger factors only in TN. Had it also mentioned their role in PH, the misdiagnosis rate might be lower. Other features making it possible to differentiate between these two conditions are CAS (present in PH, absent in the majority of TN cases, with exception for TN of the first branch), the duration of the pain (from a few seconds to 2 minutes in TN versus 2–30 minutes in PH), and the nocturnal occurrence of attacks (possible in PH, awakening the patient from sleep, but unusual in TN) [22]. The possibility of PH-tic syndrome, similar to cluster-tic syndrome, should also be borne in mind, even though it is a very rare condition [40]. Cervicogenic headache (CEH) is a unilateral side-locked headache associated with evidence of cervical involvement (provocation of pain by movement of the neck or by pressure on the neck) [41]. CEH seems to be the most frequently occurring of the hitherto well-known, unilateral headaches. i.e. at 2.2% [42]. Because PH is also a unilateral side-locked headache that can be triggered by neck movement/external pressure in which the pain sometimes involves the neck and occipital areas [38], it can be mistaken for CEH. Although this review did not identify published cases of PH clearly misdiagnosed as CEH, in the authors’ clinical experience this wrong diagnosis can occur. Elements to consider in order to distinguish PH from CEH are: associated CAS (present in PH, absent in CEH), the intensity of the pain (severe or excruciating in PH, moderate in CEH), and its temporal pattern (frequent, short-lasting attacks in PH, versus pain episodes of varying duration or fluctuating continuous pain in CEH). A complete response to indomethacin administration and/or a lack of efficacy of root-nerve blockade further corroborate a diagnosis of PH. Benoliel and Sharav considered the difficulty of differentiating CH from PH, given the broad clinical overlap between the two conditions, although they did not report specific cases of misdiagnosis [22]. In this regard, it is helpful to remember some differences between the two conditions such as frequency and duration of attacks (more frequent and shorter in PH than in CH), the sex dominance (male in CH and female in PH) and the patient behavior during the attacks (restless/agitated in CH and generally more quiet in PH). A positive response to indomethacin administration (the Indotest) is a sine qua non for the diagnosis of CPH [35]. A properly administered Indotest would prevent not only an incorrect diagnosis, but also the possibility to be prescribed with inappropriate treatment, pharmacological or surgical (multiple tooth extractions, stellate ganglion blocks, cervical sympathetic blocks, trigeminal sensory root section, infraorbital nerve section, sphenopalatine anesthetic injection and gangliectomy, infiltration of the point of Arnold, ethmoidosphenectomy) [25, 38].

SUNCT

We identified only two published cases of SUNCT misdiagnosed as other conditions; in both cases TN was one of the wrongly diagnosed conditions. Differentiating SUNCT from TN can be challenging, because the conditions have significantly overlapping clinical phenotypes. The main aspects to take into account include: autonomic features (prevalent in SUNCT and rare in TN), the localization of the pain (V1 in SUNCT and V2/3 in TN), and refractory periods (absent in SUNCT and present in TN) [43]. Primary stabbing headache (PSH) is an idiopathic condition, commonly experienced also by people with other primary headaches such as migraine (about 40%) and CH (about 30%). PSH is characterized by unilateral but erratic, moderate-to-severe, jabbing or stabbing pain, lasting from a fraction of a second to 3 seconds [1] or more (in the Vågå study there were also cases of “prolonged jabs” that may last 10–120 sec). PSH can be differentiated from SUNCT on the basis of the site and radiation of the pain (that often varies from one attack to the other), the lack of CAS and triggers [44], and the shorter duration of the attacks (usually less than five seconds, versus a mean of 49 seconds in SUNCT) [45]. SUNCT can also be misdiagnosed as dental pain. A review of TACs from the perspective of their implications for dentistry reported cases in which patients with SUNCT, in addition to experiencing facial pain, complained of pain radiating to adjacent teeth [37]. This resulted in therapeutic interventions for dental pain, such as extractions, occlusal splints and incorrect drug treatments. Other therapeutic errors have stemmed from incorrect diagnosis of SUNCT as primary headache syndromes such as TN, atypical migraine, and CH (see Table 3).

Hemicrania continua

There are several reported cases of HC mimicking dental pain or TMD. According to a review and case reports on HC, patients can mistake their HC symptoms for toothache or TMD [14, 46]. Rossi et al. described 25 patients fulfilling the ICHD-II criteria for HC selected among 1612 subjects attending an Italian Headache Center over a three-year period. Fifty-two percent of these patients had previously been misdiagnosed with migraine [15]. This is probably due to the fact that certain migraine features (pain-related ones and associated symptoms) can also occur in HC. Indeed the 40% of the HC patients described by Rossi et al. met the ICHD-II criteria for migraine during HC pain exacerbations [15]. A less common feature of HC that might easily lead to misdiagnosis is the occurrence, reported in four patients, of migraine aura before or during the pain exacerbation [47]. Seven of the 25 HC patients described by Rossi et al. had previously been incorrectly diagnosed with CH [15]. According to the authors, this was probably due to the fact that 32% of their HC patients fulfilled the diagnostic criteria for CH during pain exacerbations, and also to the tendency of HC patients to describe only their most severe headache, failing to report the presence of a persistent low-level headache. This might lead to a wrong diagnosis: physicians who investigating a case of episodic head/facial pain syndrome should always seek to establish whether the patient also experiences a lower intensity pain. We identified four cases (reported in three different papers [15, 20, 21]) of HC patients wrongly diagnosed with CEH. Both CEH and HC are side-locked unilateral headaches with a continuous temporal pattern (CEH can have either an episodic or a continuous fluctuating pattern) that can be accompanied by signs and symptoms of neck involvement (always present in CEH, and common in HC too [48]) and by migrainous features [48] (although the degree and the frequency of these associated features is different – i.e. the mean ratio migraine/CEH for the presence of other symptoms were almost 5 for nausea, 4 for throbbing quality of pain, ca 3.5 for photophobia [42]). The response to the Indotest and/or to anesthetic blockade can definitively differentiate between these two similar conditions [35]. SH as a misdiagnosis of HC was reported not only by Rossi et al. [15] but also in the Sinus, Allergy and Migraine Study [11]. The most important clinical difference concerns the nasal discharge (clear and fluid in HC but “infectious” in SH). In the routine clinical work-up, nasal endoscopic data, CT and/or MRI imaging and/or laboratory evidence of acute or acute-on-chronic rhinosinusitis are needed, diagnostically [1]. Therapeutic errors in HC are always secondary to misdiagnosis of the condition (as in PH, indomethacin response is a diagnostic criterion of HC) and patients can undergo not only wrong pharmacological treatments, but also unnecessary dental extractions, TMD or ENT surgery, physical therapy, or complementary and alternative medicine therapies [15, 20, 21, 23].

Discussion and conclusions

In this study, we set out to collect, for the first time, all the original papers referring to diagnostic and therapeutic errors in TACs and HC. Our Medline search strategy detected 13 original articles out of the overall 22 papers that we were able to find in literature (including also the manual search) and that were focused on this topic. These 13 manuscripts included all the major studies conducted in this area; indeed, 2593 of the total of 2614 patients were from studies reported in these 13 manuscripts. On this basis, the Pubmed search strategy that we set up can be deemed satisfactory. On the other hand, we cannot exclude the possibility that our search methods missed some articles not specifically focusing on this topic, but nevertheless containing data of interest for our purposes. Moreover, the likelihood that all data on errors in diagnosis and/or management of these conditions cannot be found in the literature is overwhelming. Not all physicians are inclined to report and/or search and publish “errors”. This is true not just for TACs and HC, but generally for all diseases. Nevertheless we have tried to supplement the relatively scarce literature data by also reporting our own experiences in clinical practice, and the experiences of colleagues (reported to us directly or at conferences).

A novel aspect of this study was the attempt to identify the causes of errors (and the context in which they occurred) in order to understand them better and offer advice on how they might be avoided.

Some of the diagnostic errors identified in this study derived from the fact that non-headache specialists (not only general physician but also ENT surgeons, ophthalmologists and dentists) often are unaware of the less common nosological entities. There is thus a need for specific training in this regard. However, the reported literature also shows that neurologists and headache specialists are liable to making diagnostic mistakes. There may be different reasons for this. The fact that the best diagnostic tool for headache disorders, ICHD-II (well-known and frequently consulted by headache specialists), fails to mention certain clinical features shared by TACs and HC, such as the localization of the pain (which frequently involves the midface, teeth and TMJ, and can switch sides) and associated symptoms (gastrointestinal, photo/phonophobia, aura, etc.) might lead even headache experts to making wrong diagnoses. To reduce the frequency of diagnostic errors, we suggest that these elements should be included in the forthcoming ICHD-III, at least in the comments sections.

The majority of the observed therapeutic errors are due to misdiagnoses. However, even correct diagnoses are no guarantee of an optimal therapeutic approach. For example, drugs not constituting the first-line treatment were reportedly prescribed for correctly diagnosed CH [6], in spite of the availability of updated international therapeutic guidelines for this condition [5].

In conclusion, the results of this review underline the need, alongside the current useful international diagnostic criteria and therapeutic guidelines, for more education concerning TACs and HC, in order to improve their recognition and management.